Instrument Inactif

Autres langues Protalix Biotherapeutics Inc TEL AVIV STOCK EXCHANGE

Actions

US74365A1016

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results	15/03
Protalix BioTherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	14/03
Protalix BioTherapeutics to Announce Fiscal Year 2023 Financial and Business Results on March 14, 2024	08/03
Protalix BioTherapeutics to Participate in the 2024 BIO CEO and Investor Conference	26/02
Protalix BioTherapeutics Reports Third Quarter 2023 Financial and Business Results	07/11
Protalix BioTherapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	06/11
Protalix: Q3 Earnings Snapshot	06/11
Earnings Flash (PBDA) PROTALIX BIOTHERAPEUTICS Reports Q3 Revenue $10.3M	06/11
Protalix BioTherapeutics to Announce Third Quarter 2023 Financial and Business Results on November 6, 2023	31/10/23
Protalix BioTherapeutics : PLX Corporate Presentation (October 2023)	23/10/23
Protalix BioTherapeutics Issues Statement Regarding Security Situation in Israel	10/10/23
Protalix BioTherapeutics Appoints Eliot Richard Forster, Ph.D. as Chairman of its Board of Directors	13/09/23
Protalix Biotherapeutics Appoints Eliot Richard Forster to Succeed Zeev Bronfeld as Chairman, Effective as of September 14, 2023	12/09/23
Protalix BioTherapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference	07/09/23
Protalix BioTherapeutics Reports Second Quarter 2023 Financial and Business Results	08/08/23
Protalix BioTherapeutics : PLX Corporate Presentation (August 2023)	07/08/23
Earnings Flash (PBDA) PROTALIX BIOTHERAPEUTICS Reports Q2 Revenue $35.1M	07/08/23
Protalix BioTherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	07/08/23
Protalix BioTherapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference	02/08/23
Protalix BioTherapeutics to Announce Second Quarter 2023 Financial and Business Results on August 7, 2023	01/08/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Protalix Biotherapeutics Inc TEL AVIV STOCK EXCHANGE

Actions

US74365A1016

Autres langues

Filtres